دورية أكاديمية

Plasma biomarkers in carbon monoxide poisoning.

التفاصيل البيبلوغرافية
العنوان: Plasma biomarkers in carbon monoxide poisoning.
المؤلفون: Thom SR; Department of Emergency Medicine, University of Pennsylvania, Philadelphia, PA, USA. sthom@mail.med.upenn.edu, Bhopale VM, Milovanova TM, Hardy KR, Logue CJ, Lambert DS, Troxel AB, Ballard K, Eisinger D
المصدر: Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2010 Jan; Vol. 48 (1), pp. 47-56.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 101241654 Publication Model: Print Cited Medium: Internet ISSN: 1556-9519 (Electronic) Linking ISSN: 15563650 NLM ISO Abbreviation: Clin Toxicol (Phila) Subsets: MEDLINE
أسماء مطبوعة: Publication: London : Informa Healthcare
Original Publication: Philadelphia, PA : Taylor & Francis, c2005-
مواضيع طبية MeSH: Carbon Monoxide Poisoning/*blood, Adult ; Autoantibodies/blood ; Biomarkers ; Blood Proteins/analysis ; Carbon Monoxide Poisoning/therapy ; Carboxyhemoglobin/analysis ; Chemokines/blood ; Cytokines/blood ; Female ; Hormones/blood ; Humans ; Intercellular Signaling Peptides and Proteins/blood ; Interleukins/blood ; Male ; Middle Aged ; Neurotoxicity Syndromes/physiopathology ; Pilot Projects ; Smoke Inhalation Injury/physiopathology ; Treatment Outcome ; Young Adult
مستخلص: Objectives: The severity of acute carbon monoxide (CO) poisoning is often based on non-specific clinical criteria because there are no reliable laboratory markers. We hypothesized that a pattern of plasma protein values might objectively discern CO poisoning severity. This was a pilot study to evaluate protein profiles in plasma samples collected from patients at the time of initial hospital evaluation. The goal was to assess whether any values differed from age- and sex-matched controls using a commercially available plasma screening package.
Methods: Frozen samples from 63 suspected CO poisoning patients categorized based on clinical signs, symptoms, and blood carboxyhemoglobin level were analyzed along with 42 age- and sex-matched controls using Luminex-based technology to determine the concentration of 180 proteins.
Results: Significant differences from control values were found for 99 proteins in at least one of five CO poisoning groups. A complex pattern of elevations in acute phase reactants and proteins associated with inflammatory responses including chemokines/cytokines and interleukins, growth factors, hormones, and an array of auto-antibodies was found. Fourteen protein values were significantly different from control in all CO groups, including patients with nominal carboxyhemoglobin elevations and relatively brief intervals of exposure.
Conclusions: The data demonstrate the complexity of CO pathophysiology and support a view that exposure causes acute inflammatory events in humans. This pilot study has insufficient power to discern reliable differences among patients who develop neurological sequelae but future trials are warranted to determine whether plasma profiles predict mortality and morbidity risks of CO poisoning.
References: JAMA. 2006 Jan 25;295(4):398-402. (PMID: 16434630)
Free Radic Biol Med. 2006 Apr 15;40(8):1332-9. (PMID: 16631523)
Biol Psychiatry. 1997 May 15;41(10):1000-9. (PMID: 9129780)
J Thromb Haemost. 2007 Feb;5(2):252-60. (PMID: 17083648)
Trends Pharmacol Sci. 2007 May;28(5):200-5. (PMID: 17416426)
Toxicol Appl Pharmacol. 1995 Jun;132(2):196-202. (PMID: 7785048)
Toxicol Appl Pharmacol. 1993 Dec;123(2):234-47. (PMID: 8248931)
Environ Res. 2008 Jan;106(1):51-61. (PMID: 17915210)
J Pharmacol Exp Ther. 1978 Jul;206(1):61-8. (PMID: 660558)
Biochem Biophys Res Commun. 2008 Mar 14;367(3):674-9. (PMID: 18174021)
J Pharmacol Exp Ther. 1991 Jan;256(1):378-84. (PMID: 1671097)
Free Radic Biol Med. 1997;22(4):725-32. (PMID: 9013136)
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13660-5. (PMID: 15342916)
Lancet. 1989 Aug 19;2(8660):414-9. (PMID: 2569600)
Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G184-91. (PMID: 17991708)
Am J Respir Crit Care Med. 2007 Sep 1;176(5):491-7. (PMID: 17496229)
Inhal Toxicol. 2006 Feb;18(2):155-8. (PMID: 16393930)
Can Med Assoc J. 1977 Sep 17;117(6):654, 657. (PMID: 902215)
Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1649-53. (PMID: 14704226)
Free Radic Biol Med. 2004 Dec 1;37(11):1802-12. (PMID: 15528039)
N Engl J Med. 2002 Oct 3;347(14):1057-67. (PMID: 12362006)
FASEB J. 2005 Feb;19(2):284-6. (PMID: 15556971)
Am J Respir Crit Care Med. 2006 Dec 1;174(11):1239-48. (PMID: 16931637)
Chem Res Toxicol. 1997 Sep;10(9):1023-31. (PMID: 9305585)
Curr Pharm Des. 2003;9(30):2525-39. (PMID: 14529551)
Am J Physiol. 1999 Mar;276(3):H984-92. (PMID: 10070083)
Nat Med. 2001 May;7(5):598-604. (PMID: 11329062)
Environ Health Perspect. 2007 Jul;115(7):1072-80. (PMID: 17637925)
Scand J Clin Lab Invest Suppl. 1968;103:49-54. (PMID: 5720768)
J Pharmacol Exp Ther. 1992 Apr;261(1):349-52. (PMID: 1532836)
Circ Res. 2007 Oct 26;101(9):919-27. (PMID: 17823375)
Biochem Biophys Res Commun. 1991 Sep 16;179(2):836-40. (PMID: 1832862)
J Am Coll Cardiol. 2005 May 3;45(9):1513-6. (PMID: 15862427)
Circ Res. 2003 Jul 25;93(2):e2-8. (PMID: 12842916)
Circ Res. 2002 Feb 8;90(2):E17-24. (PMID: 11834719)
Bioessays. 2004 Mar;26(3):270-80. (PMID: 14988928)
J Expo Anal Environ Epidemiol. 2005 Jul;15(4):319-28. (PMID: 15536489)
J Immunol. 2004 Mar 15;172(6):3553-63. (PMID: 15004156)
Mol Cell Biochem. 1996 Apr 12-26;157(1-2):75-86. (PMID: 8739231)
Undersea Hyperb Med. 2007 May-Jun;34(3):163-8. (PMID: 17672172)
Acta Anaesthesiol Scand. 2004 Apr;48(4):469-73. (PMID: 15025610)
Neurosci Lett. 1990 Jan 22;108(3):321-7. (PMID: 2154727)
Free Radic Biol Med. 2008 Sep 1;45(5):562-9. (PMID: 18549826)
J Biol Chem. 2003 Sep 26;278(39):36993-8. (PMID: 12857751)
J Mol Med (Berl). 2008 Mar;86(3):267-79. (PMID: 18034222)
J Clin Invest. 1992 Feb;89(2):666-72. (PMID: 1737854)
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5191-6. (PMID: 16551742)
Arch Neurol. 1983 Jul;40(7):433-5. (PMID: 6860181)
Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1305-10. (PMID: 10655526)
Ann Emerg Med. 1995 Apr;25(4):474-80. (PMID: 7710151)
Toxicol Appl Pharmacol. 1994 Sep;128(1):105-10. (PMID: 7521544)
Occup Environ Med. 2000 Dec;57(12):818-22. (PMID: 11077010)
Arch Clin Neuropsychol. 1990;5(1):59-67. (PMID: 14589544)
Resuscitation. 2004 Jun;61(3):357-60. (PMID: 15172716)
Atherosclerosis. 1972 Jul-Aug;16(1):67-82. (PMID: 5069583)
Antioxid Redox Signal. 2004 Oct;6(5):802-10. (PMID: 15345139)
Am J Cardiol. 2007 Feb 1;99(3):322-4. (PMID: 17261390)
Am J Respir Crit Care Med. 2006 Feb 15;173(4):432-41. (PMID: 16293802)
Toxicol Appl Pharmacol. 1999 Jan 1;154(1):12-9. (PMID: 9882587)
J Emerg Med. 1998 Sep-Oct;16(5):695-8. (PMID: 9752939)
J Immunol. 2004 Aug 1;173(3):2023-30. (PMID: 15265937)
Scand J Clin Lab Invest. 1972;29(4):381-8. (PMID: 20465479)
Am J Emerg Med. 2008 Jul;26(6):665-9. (PMID: 18606318)
Biochem Biophys Res Commun. 2006 May 12;343(3):965-72. (PMID: 16574070)
J Exp Med. 2003 Dec 1;198(11):1707-16. (PMID: 14657222)
Toxicology. 2000 Apr 7;145(1):1-14. (PMID: 10771127)
معلومات مُعتمدة: R01 ES005211 United States ES NIEHS NIH HHS; R01 ES005211-14 United States ES NIEHS NIH HHS; R43 ES016720 United States ES NIEHS NIH HHS; ES016720 United States ES NIEHS NIH HHS
المشرفين على المادة: 0 (Autoantibodies)
0 (Biomarkers)
0 (Blood Proteins)
0 (Chemokines)
0 (Cytokines)
0 (Hormones)
0 (Intercellular Signaling Peptides and Proteins)
0 (Interleukins)
9061-29-4 (Carboxyhemoglobin)
تواريخ الأحداث: Date Created: 20100126 Date Completed: 20100217 Latest Revision: 20211020
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC3941305
DOI: 10.3109/15563650903468209
PMID: 20095814
قاعدة البيانات: MEDLINE
الوصف
تدمد:1556-9519
DOI:10.3109/15563650903468209